Literature DB >> 17058246

Everolimus and mTOR inhibitors in liver transplantation: opening the "box".

Gregory T Everson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17058246     DOI： 10.1002/lt.20845

Source DB:  PubMed          Journal:  Liver Transpl        ISSN： 1527-6465            Impact factor:   5.799


× No keyword cloud information.
  2 in total

1.  Multiple indications for everolimus after liver transplantation in current clinical practice.

Authors:  Itxarone Bilbao; Cristina Dopazo; Jose Lazaro; Lluis Castells; Mireia Caralt; Gonzalo Sapisochin; Ramon Charco
Journal:  World J Transplant       Date:  2014-06-24

2.  Everolimus and early calcineurin inhibitor withdrawal: 3-year results from a randomized trial in liver transplantation.

Authors:  M Sterneck; G M Kaiser; N Heyne; N Richter; F Rauchfuss; A Pascher; P Schemmer; L Fischer; C G Klein; S Nadalin; F Lehner; U Settmacher; P Neuhaus; D Gotthardt; M Loss; S Ladenburger; E M Paulus; M Mertens; H J Schlitt
Journal:  Am J Transplant       Date:  2014-02-06       Impact factor: 8.086
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.